RMO LLP Continues Strategic Expansion with Four New Hires in California
News provided by
Share this article
Share this article
LOS ANGELES, March 15, 2021 /PRNewswire/ Continuing its successful pattern of recruiting top talent, probate and trust estate litigation firm RMO LLP announced today that it is expanding two of its California offices with four new hires, adding two attorneys to the firm s already impressive bench. New attorneys include Stephanie Delaney in the San Diego office, and Julie Levering in Los Angeles, along with seasoned paralegal Cristina Banuelos and experienced case manager Patricia Taylor. To meet the demands of our client s ever-increasing needs, we are excited to grow the firm and its services with the addition of these four talented women, said Co-Managing Partner Scott Rahn. Like all our attorneys and staff, Julie, Stephanie, Cristina and Patricia all have impressive credentials and essential experience. The firm s clients will undoubtedly be
The Day - Ruling brings growth and change to Norwich Transition Academy - News from southeastern Connecticut
theday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theday.com Daily Mail and Mail on Sunday newspapers.
Last-Itch Effort: Fighting the Bacteria That Exacerbate Eczema with Bacteria
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Last-Itch Effort: Fighting the Bacteria That Exacerbate Eczema with Bacteria Researchers at UC San Diego School of Medicine use bacteriotherapy to improve symptoms of atopic dermatitis February 22, 2021 | Jeanna Vazquez
News release
In a new study out of University of California San Diego School of Medicine, researchers have identified a universal strain of bacteria derived from healthy human skin that can treat the most common type of eczema, also known as atopic dermatitis.
In the paper published Feb. 22, 2021, in
Nature Medicine, the research team investigated the safety and mechanisms of this certain bacteria in a first-in-human, Phase I, double-blinded clinical trial looking to treat people living with eczema. Of the 54 participants, two-thirds reported improvements in their symptoms, including fewer complaints of itchiness and inflammation.
Last-itch effort: Fighting the bacteria that exacerbate eczema with bacteria
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.